Pediatric Annals

CME PRE-TEST

Abstract

EDUCATIONAL OBJECTIVE

Protection against infections and infectious diseases is a rapidly growing area of medicine. The practicing pediatrician has an obligation to keep abreast of the ever-changing knowledge in this area. Following completion of this Continuing Medical Education offering, participants will be updated on new applications of old antimicrobials, antiviral chemotherapy, anaerobic infections, pertussis immunization, haemophilus influenzae type b polysaccharide vaccine, and the new cephalosporins.

HOW TO OBTAIN CME CREDITS BY READING THIS ISSUE

Pediatricians can receive Category I credits for the Physician's Recognition Award of the American Medical Association by reading the following articles and successfully completing the quiz at the end of the issue. Complete instructions are given on the quiz pages.

The Pre-Test below has been prepared to assistyou in studying the folowing material, it indicates some of the areas to De covered, and will make it possible for you to challenge your present knowledge of the material before reading further.

PRE-TEST

1. Amantadlne Is most efficacious In the prophylaxis and therapy of infections with:

A. Influenza A.

B. Influenza B.

C. Parainfluenza.

D. Respiratory syncytial virus.

2. Which of the following Infections Is likely to be caused by an anaerobe?

A. Bacterial meningitis.

B. Human bite infections.

C. Septic arthritis.

D. Otitis media.

3. Which activity listed below has the highest risk of yielding a fatal outcome?

A. The acquisition of pertussis infection by an unimmunized individual.

B. Being involved in a traffic accident.

C. Manifesting pertussis vaccine-associated encephalopathy.

D. Receiving a pertussis immunization.

4. Which of the following cephalosporins would be expected to have the best activity for gram-positive Infections such as Staphylococcus aureus?

A. First-generation, eg, cephalothin.

B. Second-generation, eg, cefuroxime.

C. Third-generation, eg, ceftriaxone.

D. Any of the above (A, B, or C).…

EDUCATIONAL OBJECTIVE

Protection against infections and infectious diseases is a rapidly growing area of medicine. The practicing pediatrician has an obligation to keep abreast of the ever-changing knowledge in this area. Following completion of this Continuing Medical Education offering, participants will be updated on new applications of old antimicrobials, antiviral chemotherapy, anaerobic infections, pertussis immunization, haemophilus influenzae type b polysaccharide vaccine, and the new cephalosporins.

HOW TO OBTAIN CME CREDITS BY READING THIS ISSUE

Pediatricians can receive Category I credits for the Physician's Recognition Award of the American Medical Association by reading the following articles and successfully completing the quiz at the end of the issue. Complete instructions are given on the quiz pages.

The Pre-Test below has been prepared to assistyou in studying the folowing material, it indicates some of the areas to De covered, and will make it possible for you to challenge your present knowledge of the material before reading further.

PRE-TEST

1. Amantadlne Is most efficacious In the prophylaxis and therapy of infections with:

A. Influenza A.

B. Influenza B.

C. Parainfluenza.

D. Respiratory syncytial virus.

2. Which of the following Infections Is likely to be caused by an anaerobe?

A. Bacterial meningitis.

B. Human bite infections.

C. Septic arthritis.

D. Otitis media.

3. Which activity listed below has the highest risk of yielding a fatal outcome?

A. The acquisition of pertussis infection by an unimmunized individual.

B. Being involved in a traffic accident.

C. Manifesting pertussis vaccine-associated encephalopathy.

D. Receiving a pertussis immunization.

4. Which of the following cephalosporins would be expected to have the best activity for gram-positive Infections such as Staphylococcus aureus?

A. First-generation, eg, cephalothin.

B. Second-generation, eg, cefuroxime.

C. Third-generation, eg, ceftriaxone.

D. Any of the above (A, B, or C).

10.3928/0090-4481-19860601-03

Sign up to receive

Journal E-contents